NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed? | Zendy

Ali Canbay | Zendy; JanPeter Sowa | Zendy; WingKin Syn | Zendy; Jürgen Treckmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?

Author(s) -

Ali Canbay,

JanPeter Sowa,

WingKin Syn,

Jürgen Treckmann

Publication year - 2016

Publication title -

visceral medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.598

H-Index - 17

eISSN - 2297-475X

pISSN - 2297-4725

DOI - 10.1159/000446379

Subject(s) - steatohepatitis , medicine , metabolic syndrome , fatty liver , cirrhosis , steatosis , liver transplantation , diabetes mellitus , immunosuppression , gastroenterology , hepatocellular carcinoma , transplantation , intensive care medicine , disease , obesity , endocrinology

Non-alcoholic fatty liver disease (NAFLD) is a continuously increasing cause of chronic liver disease and a health burden in all populations affected by the obesity and metabolic syndrome pandemic. Cirrhotic alterations or hepatocellular carcinoma developing from NAFLD may require liver transplantation (LTx).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research